News & Articles

The Access for All in ALS Consortium (ALL ALS) announced the successful enrollment of the first participant. Established in the autumn of 2023 with funding from the National...

Moreno Family Chair of Alzheimer’s Research Marwan Sabbagh, MD, a behavioral neurologist in the Alzheimer’s and Memory Disorders Program at Barrow, was formally presented with the Moreno Family...

“AZ Big Media” has named Barrow Neurological Institute one of 50 influential businesses to watch in 2024, as part of their “AZ Big 100” list.

International ALS Awards Jeremy Shefner, MD, PhD, Chief Medical Officer of Clinical Research , and Robert Bowser, PhD, Chief Scientific Officer, received prestigious awards at the 34th International...

Amylyx Pharmaceuticals, Inc. today announced the publication of analyses performed on neuroinflammatory biomarkers using plasma samples from participants with amyotrophic lateral sclerosis (ALS) from the Phase 2 CENTAUR...